Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan

Reuters2021-11-10

TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.

Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.

Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.

About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

Grit100
2021-11-10
Grit100
Like n comment pls. Thx
Ivanhojh
2021-11-10
Ivanhojh
Like pls
mei2302
2021-11-10
mei2302
Singapore will likely to be the next to approve the vaccination soon too! No wonder the stock price went up…
wywy
2021-11-10
wywy
Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.
xxbbew
2021-11-10
xxbbew
Like
- JQing:
  👍
senglee
2021-11-10
senglee
Okok
- xxbbew:
  Ok
- senglee:
  okok

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2182408236?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-10 14:57","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2182408236","market":"us","top_or_hot":-1,"title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","media":"Reuters","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","article_id":"2182408236","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","pubTimestamp":1636527423,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"辉瑞申请日本5-11岁儿童新冠疫苗批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.9},"content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[{"id":847530670,"gmtCreate":1636533164532,"gmtModify":1636533324882,"author":{"id":"3581502897038686","authorId":"3581502897038686","name":"Grit100","avatar":"https://static.tigerbbs.com/c3c65cb20cfcce91cc07fddb27bc3ccd","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581502897038686","authorIdStr":"3581502897038686"},"htmlText":"Like n comment pls. Thx","listText":"Like n comment pls. Thx","text":"Like n comment pls. Thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847530670","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","kind":"news","pubTimestamp":1636527423,"share":"https://ttm.financial/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":847242892,"gmtCreate":1636529323359,"gmtModify":1636529416455,"author":{"id":"3575241823069388","authorId":"3575241823069388","name":"Ivanhojh","avatar":"https://static.tigerbbs.com/a41f0bf4ce9ad13477b3d5ba49c8d025","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3575241823069388","authorIdStr":"3575241823069388"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847242892","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","kind":"news","pubTimestamp":1636527423,"share":"https://ttm.financial/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":847246489,"gmtCreate":1636529265237,"gmtModify":1636530080566,"author":{"id":"3581653206217934","authorId":"3581653206217934","name":"mei2302","avatar":"https://static.tigerbbs.com/f8d4a2b017d4591be698aae349b7d2ce","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581653206217934","authorIdStr":"3581653206217934"},"htmlText":"Singapore will likely to be the next to approve the vaccination soon too! No wonder the stock price went up…&nbsp;","listText":"Singapore will likely to be the next to approve the vaccination soon too! No wonder the stock price went up…&nbsp;","text":"Singapore will likely to be the next to approve the vaccination soon too! No wonder the stock price went up…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847246489","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","kind":"news","pubTimestamp":1636527423,"share":"https://ttm.financial/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":847243721,"gmtCreate":1636528703632,"gmtModify":1636530086568,"author":{"id":"3566982670449095","authorId":"3566982670449095","name":"wywy","avatar":"https://static.tigerbbs.com/76ed86374fc7b16c12094c45ea30787c","vip":2,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3566982670449095","authorIdStr":"3566982670449095"},"htmlText":"&nbsp;Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.","listText":"&nbsp;Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.","text":"Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847243721","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","kind":"news","pubTimestamp":1636527423,"share":"https://ttm.financial/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":847243143,"gmtCreate":1636528636089,"gmtModify":1636528657806,"author":{"id":"3573467106982618","authorId":"3573467106982618","name":"xxbbew","avatar":"https://static.tigerbbs.com/39068f2ebe66e4e0b64c90ad557577c0","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3573467106982618","authorIdStr":"3573467106982618"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/847243143","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","kind":"news","pubTimestamp":1636527423,"share":"https://ttm.financial/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6522950,"gmtCreate":1636528909508,"gmtModify":1636528909537,"authorId":3575867559801093,"author":{"id":3575867559801093,"idStr":"3575867559801093","authorId":3575867559801093,"name":"JQing","avatar":"https://static.tigerbbs.com/ed5b621dfa986aa908cbc70f2a608ac8","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":847243143,"type":1,"supId":0,"prevId":0,"content":"👍","text":"👍","html":"👍"}],"langContent":"CN"},{"id":847240006,"gmtCreate":1636528251970,"gmtModify":1636528252211,"author":{"id":"3567638399995673","authorId":"3567638399995673","name":"senglee","avatar":"https://static.tigerbbs.com/0c8e58d61d01e30569a28e4e9c648c8f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3567638399995673","authorIdStr":"3567638399995673"},"htmlText":"Okok","listText":"Okok","text":"Okok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/847240006","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","kind":"news","pubTimestamp":1636527423,"share":"https://ttm.financial/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6522924,"gmtCreate":1636528640762,"gmtModify":1636528640874,"authorId":3573467106982618,"author":{"id":3573467106982618,"idStr":"3573467106982618","authorId":3573467106982618,"name":"xxbbew","avatar":"https://static.tigerbbs.com/39068f2ebe66e4e0b64c90ad557577c0","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":847240006,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":6522875,"gmtCreate":1636528287864,"gmtModify":1636528287891,"authorId":3567638399995673,"author":{"id":3567638399995673,"idStr":"3567638399995673","authorId":3567638399995673,"name":"senglee","avatar":"https://static.tigerbbs.com/0c8e58d61d01e30569a28e4e9c648c8f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":847240006,"type":1,"supId":0,"prevId":0,"content":"<u>okok</u>","text":"<u>okok</u>","html":"<u>okok</u>"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":19,"commentSize":8,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2182408236"}